Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans

Seroefficacy of Vi Polysaccharide–Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)

(2018) Merryn Voysey et al.   CLINICAL INFECTIOUS DISEASES

Typhoid vaccine development with a human challenge model

(2017) Nicholas A Feasey et al.   LANCET

Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study

(2016) Monjori Mitra et al.   Human Vaccines & Immunotherapeutics

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

(2015) Vadrevu Krishna Mohan et al.   CLINICAL INFECTIOUS DISEASES

Typhoid fever

(2015) John Wain et al.   LANCET

Salmonella entericaSerovar Typhi and the Pathogenesis of Typhoid Fever

(2014) Gordon Dougan et al.   Annual Review of Microbiology

An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution

(2014) Claire S. Waddington et al.   CLINICAL INFECTIOUS DISEASES

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

(2014) Vittal Mogasale et al.   Lancet Global Health

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

(2013) Zulfiqar A Bhutta et al.   LANCET INFECTIOUS DISEASES

Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan

(2012) M. Imran Khan et al.   Journal of Infection in Developing Countries

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

(2011) Vu Dinh Thiem et al.   Clinical and Vaccine Immunology

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults

(2011) Pierre van Damme et al.   PLoS One